Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
adhesion G protein-coupled receptor V1 | 0.572 | 0.731 | 3.2E-39 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
ankyrin repeat domain 7 | 0.890 | 0.346 | 4.3E-06 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
autophagy related 5 | 0.462 | 0.885 | 0.98 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
ATPase plasma membrane Ca2+ transporting 2 | 0.659 | 0.731 | 1.00 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2011 | 2018 | ||||||||
|
barttin CLCNK type accessory subunit beta | 0.603 | 0.692 | 1.1E-10 |
|
disease | 0.010 | None | 1.000 | 1 | 1 | 2003 | 2003 | ||||||||
|
calcium voltage-gated channel subunit alpha1 C | 0.510 | 0.846 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
calcium voltage-gated channel subunit alpha1 D | 0.582 | 0.577 | 1.00 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2011 | 2014 | ||||||||
|
cadherin related 23 | 0.539 | 0.769 | 3.2E-06 |
|
disease | 0.030 | None | 1.000 | 3 | 1 | 2011 | 2016 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
cyclin dependent kinase inhibitor 2D | 0.547 | 0.769 | 0.49 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
CEA cell adhesion molecule 16, tectorial membrane component | 0.805 | 0.192 | 1.6E-05 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
chloride voltage-gated channel Kb | 0.593 | 0.692 | 1.4E-22 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
claudin 14 | 0.705 | 0.462 | 1.1E-04 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
Carney complex type 2, multiple neoplasia and lentiginosis | 0.674 | 0.692 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
collagen type IX alpha 3 chain | 0.569 | 0.769 | 3.3E-12 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
cystatin B | 0.530 | 0.692 | 6.6E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
Diamond-Blackfan anemia 2 | 0.599 | 0.731 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
deafness, autosomal recessive 17 | 0.931 | 0.192 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 | |||||||||
|
endothelin receptor type B | 0.470 | 0.846 | 9.2E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
estrogen related receptor gamma | 0.621 | 0.692 | 7.1E-02 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2016 | 2016 | ||||||||
|
EYA transcriptional coactivator and phosphatase 1 | 0.531 | 0.731 | 0.95 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
coagulation factor IX | 0.465 | 0.885 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
fibroblast growth factor 3 | 0.505 | 0.808 | 9.3E-05 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2008 | 2009 | ||||||||
|
growth arrest specific 1 | 0.587 | 0.654 | 0.82 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
GATA binding protein 2 | 0.496 | 0.654 | 0.98 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 |